Core A: Administrative

摘要-核心A（管理核心） C.艰难抑制”计划（mVACS）由一个高度互动的团队组成， 研究人员正在寻求开发一种mRNA疫苗平台， 艰难梭菌相关感染和疾病。项目1是生成和测试的引擎 修饰的mRNA疫苗（项目1 -疫苗开发）。这一努力的加速和指导是： 探索菌株多样性和微生物生态学的项目（项目2 -抗原发现）和粘膜 对自然感染的适应性免疫反应（项目3 -免疫学）。支持这三个项目的是 两个科学核心，将提供专业知识，技术技能和大型深度测序数据集的分析 (Core B -基因组学核心），并收集患者队列的样品（核心C -临床核心）。芯A （行政核心）是该计划的后勤和组织组成部分，将处理定期 确保数据和信息的无缝交换。核心A（行政 核心）是共同领导的mVACS项目主任博士布什曼和博士韦斯曼。其主要目标将 监督计划的科学进展，监督资源分配，促进项目 互动和数据集成，确保遵守NIH指南，并促进科学事业 mVACS团队的发展。

SUMMARY – CORE A (Administration Core) The "mRNA Vaccines for C. difficile Suppression” program (mVACS) consists of a highly interactive team of investigators who are seeking to develop an mRNA vaccine platform to provide protection against Clostridioides difficile-associated infection and disease. Project 1 is the engine for generating and testing modified mRNA vaccines (Project 1 – Vaccine Development). This effort is accelerated and guided by projects exploring strain diversity and microbial ecology (Project 2 – Antigen Discovery) and the mucosal adaptive immune response to natural infection (Project 3 – Immunology). Supporting these three projects are two scientific cores that will provide expertise, technical skills, and analysis of large deep-sequencing datasets (Core B - Genomics Core), and collect samples for a patient cohort (Core C - Clinical Core). Core A (Administrative Core) is the logistical and organizational component of the program that will handle regular inter-project communication and ensure seamless exchange of data and information. Core A (Administrative Core) is co-led by the mVACS program directors Dr. Bushman and Dr. Weissman. Their primary objectives will be to monitor the scientific progress of the program, oversee distribution of resources, stimulate project interactions and data integration, ensure compliance with NIH guidelines, and promote the scientific career development of the mVACS team.